Literature DB >> 25711742

A novel vascular pattern promotes metastasis of hepatocellular carcinoma in an epithelial-mesenchymal transition-independent manner.

Jian-Hong Fang1, Hui-Chao Zhou2, Chong Zhang1, Li-Ru Shang1, Lei Zhang2, Jing Xu3, Limin Zheng1, Yunfei Yuan3, Rong-Ping Guo3, Wei-Hua Jia4, Jing-Ping Yun5, Min-Shan Chen3, Yaojun Zhang3, Shi-Mei Zhuang1,2.   

Abstract

UNLABELLED: Early metastasis is responsible for frequent relapse and high mortality of hepatocellular carcinoma (HCC), but its underlying mechanisms remain unclear. Epithelial-mesenchymal transition (EMT) has been considered a key event in metastasis. Based on histological examination of serial HCC sections and three-dimensional reconstruction, we found a novel and prevalent vascular pattern, vessels that encapsulated tumor clusters (VETC) and formed cobweb-like networks. The presence of VETC (VETC(+) ) predicted higher metastasis and recurrence rates of HCC. Using clinical samples and mouse xenograft models, we further showed that VETC was composed of functional vessels with blood perfusion and induced by tumor cells at the early stage of HCC. Subsequent investigations revealed that HCC cell-derived angiopoietin-2 was a prerequisite for VETC formation and that the VETC pattern was a critical factor promoting HCC metastasis as knockdown of angiopoietin-2 abolished this vascular pattern and consequently attenuated in vivo tumor metastasis. Interestingly, abrogation of EMT by knockdown of Snail or Slug significantly diminished in vivo metastasis of VETC(-) xenografts but did not affect that of VETC(+) ones, although silencing of Snail or Slug substantially reduced the in vitro migration of both VETC(+) and VETC(-) HCC cells. In contrast to human VETC(-) cases, EMT signatures were rarely observed in VETC(+) cases with metastatic potential. Further analysis revealed that VETC provided an efficient metastasis mode by facilitating the release of whole tumor clusters into the bloodstream.
CONCLUSION: Our findings identify a novel metastasis mechanism that relies on vascular pattern but is independent of EMT, which may provide new targets for antimetastasis therapy and offer a basis for selecting patients who may benefit from certain molecularly targeted drugs.
© 2015 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25711742     DOI: 10.1002/hep.27760

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  51 in total

1.  A new VETC in hepatocellular carcinoma metastasis.

Authors:  Kaisa L Hanley; Gen-Sheng Feng
Journal:  Hepatology       Date:  2015-06-03       Impact factor: 17.425

Review 2.  [Surgical treatment of hepatic tumors-liver resection and transplantation].

Authors:  H Lang; S Heinrich; F Bartsch; F Hüttl; J Baumgart; J Mittler
Journal:  Internist (Berl)       Date:  2020-02       Impact factor: 0.743

3.  Dual angiogenesis and PD-1 blockade in hepatocellular carcinoma.

Authors:  Julien Calderaro
Journal:  Hepatobiliary Surg Nutr       Date:  2020-06       Impact factor: 7.293

Review 4.  Clinico-Radio-Pathological and Molecular Features of Hepatocellular Carcinomas with Keratin 19 Expression.

Authors:  Hyungjin Rhee; Haeryoung Kim; Young Nyun Park
Journal:  Liver Cancer       Date:  2020-10-23       Impact factor: 11.740

5.  Monocytes/Macrophages promote vascular CXCR4 expression via the ERK pathway in hepatocellular carcinoma.

Authors:  Ya-Ming Meng; Jing Liang; Chong Wu; Jing Xu; Dan-Ni Zeng; Xing-Juan Yu; Huiheng Ning; Li Xu; Limin Zheng
Journal:  Oncoimmunology       Date:  2017-12-13       Impact factor: 8.110

6.  Lymphocyte-to-C-reactive protein ratio as a prognostic factor for hepatocellular carcinoma.

Authors:  Norifumi Iseda; Shinji Itoh; Tomoharu Yoshizumi; Takahiro Tomiyama; Akinari Morinaga; Tomonari Shimagaki; Huanlin Wang; Takeshi Kurihara; Takeo Toshima; Yoshihiro Nagao; Noboru Harada; Yoshinao Oda; Masaki Mori
Journal:  Int J Clin Oncol       Date:  2021-07-12       Impact factor: 3.402

7.  Decreased Expression of EHD2 Promotes Tumor Metastasis and Indicates Poor Prognosis in Hepatocellular Carcinoma.

Authors:  Jinxia Liu; Wenkai Ni; Lishuai Qu; Xiaopeng Cui; Zhipeng Lin; Qingqing Liu; Huiling Zhou; Runzhou Ni
Journal:  Dig Dis Sci       Date:  2016-05-25       Impact factor: 3.199

8.  Hepatocellular Carcinoma with Irregular Rim-Like Arterial Phase Hyperenhancement: More Aggressive Pathologic Features.

Authors:  Hyungjin Rhee; Chansik An; Hye-Young Kim; Jeong Eun Yoo; Young Nyun Park; Myeong-Jin Kim
Journal:  Liver Cancer       Date:  2018-05-15       Impact factor: 11.740

9.  Finally, a Minimally Invasive Option for Intrahepatic Inferior Vena Cava Invasion by Hepatocellular Carcinoma.

Authors:  Erik Soule; Jerry Matteo
Journal:  Gastrointest Tumors       Date:  2018-08-17

10.  Texture Analysis Based on Gd-EOB-DTPA-Enhanced MRI for Identifying Vessels Encapsulating Tumor Clusters (VETC)-Positive Hepatocellular Carcinoma.

Authors:  Yanfen Fan; Yixing Yu; Ximing Wang; Mengjie Hu; Mingzhan Du; Lingchuan Guo; Shifang Sun; Chunhong Hu
Journal:  J Hepatocell Carcinoma       Date:  2021-05-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.